Barbara Ma

844 citations

17 papers · 648 indexed · h-index 13

Impact in

Immunology top 10%
- Immunotherapy and Immune Responses
Epidemiology top 10%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies

Papers in ⓘ

Immunology 13
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 3
Oncology 8
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 2

Co-authors: Chien‐Fu Hung (11 shared papers)T.‐C. Wu (9 shared papers)Archana Monie (3 shared papers)T-C Wu (3 shared papers)Ken Y. Lin (1 shared paper)Anjui Wu (1 shared paper)Yijie Xu (2 shared papers)Niroshana Anandasabapathy (1 shared paper)
Journals: Molecular Therapy (2 papers)Vaccine (2 papers)Cell & Bioscience (1 paper)Cancer (1 paper)Journal of Investigative Dermatology (1 paper)
Partner nations: United States Taiwan United Kingdom

In The Last Decade

Barbara Ma

16 papers receiving 626 citations

Peers

Countries citing papers authored by Barbara Ma

Since Specialization

Citations

This map shows the geographic impact of Barbara Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Ma more than expected).

Fields of papers citing papers by Barbara Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Ma. The network helps show where Barbara Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Ma Line = papers co-authored together Barbara Ma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Therapeutic human papillomavirus vaccines: current clinical trials and future directions Expert Opinion on Biological Therapy ·Chien‐Fu Hung, Barbara Ma, Archana Monie, Shaw-Wei Tsen, T-C Wu	2008	144
2	Therapeutic HPV DNA vaccines Immunologic Research ·Ken Y. Lin, Elena Roosinovich, Barbara Ma, Chien‐Fu Hung, T.‐C. Wu	2010	98
3	Immunotherapy for Cervical Cancer BioDrugs ·Jun-Han Su, Anjui Wu, Elizabeth Scotney, Barbara Ma, Archana Monie, Chien‐Fu Hung, T.‐C. Wu	2010	90
4	Emerging human papillomavirus vaccines Expert Opinion on Emerging Drugs ·Barbara Ma, Bharat Maraj, Nam Phuong Tran, Jayne Knoff, Alexander Chen, Ronald D. Alvarez, Chien‐Fu Hung, T.‐C. Wu	2012	67
5	Development of a DNA vaccine targeting Merkel cell polyomavirus Vaccine ·Qi Zeng, Bianca Gomez, Raphael P. Viscidi, Shiwen Peng, Liangmei He, Barbara Ma, T-C Wu, Chien‐Fu Hung	2011	50
6	Treatment With Cyclooxygenase-2 Inhibitors Enables Repeated Administration of Vaccinia Virus for Control of Ovarian Cancer Molecular Therapy ·Chih-Long Chang, Barbara Ma, Xiaowu Pang, T.‐C. Wu, Chien‐Fu Hung	2009	43
7	LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines Vaccine ·Tong Zhang, Tae Heung Kang, Barbara Ma, Yijie Xu, Chien‐Fu Hung, T.‐C. Wu	2011	38
8	HPV and Therapeutic Vaccines: Where are We in 2010? Current Cancer Therapy Reviews ·Barbara Ma, Yijie Xu, Chien‐Fu Hung, T.‐C. Wu	2010	28
9	Immune Checkpoint Blockade and Skin Toxicity Pathogenesis Journal of Investigative Dermatology ·Barbara Ma, Niroshana Anandasabapathy	2021	18
10	Current Status of Human Papillomavirus Vaccines Journal of the Formosan Medical Association ·Barbara Ma, Richard B.S. Roden, T.‐C. Wu	2010	17
11	Targeted Coating With Antigenic Peptide Renders Tumor Cells Susceptible to CD8+ T Cell-mediated Killing Molecular Therapy ·Tae Heung Kang, Barbara Ma, Connie Wang, T.‐C. Wu, Chien‐Fu Hung	2012	14
12	Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors Cancer Immunology Immunotherapy ·Chao-Yi Wu, Huang‐Yu Yang, Archana Monie, Barbara Ma, Hsiao-Hsuan Tsai, T.‐C. Wu, Chien‐Fu Hung	2011	14
13	A multidisciplinary management algorithm for brain metastases Neuro-Oncology Advances ·Alexander Ramos, Alexandra Giantini-Larsen, Susan C. Pannullo, Andrew Brandmaier, Jonathan Knisely, Rajiv Magge, Jessica Wilcox, Anna C. Pavlick, Barbara Ma, David J. Pisapia, Hani Ashamalla, Rohan Ramakrishna	2022	12
14	The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study Cancer ·Shaked Lev‐Ari, Michael Serzan, Tianmin Wu, Andrew Ip, L.C. Fernando Pascual, Brittany Sinclaire, Shari Adams, Michael Marafelias, Lakshmi Ayyagari, Sarvarinder Gill, Barbara Ma, Jacob P. Zaemes, Alexandra Della Pia, Adil Alaoui, Subha Madhavan, Anas Belouali, Andrew L. Pecora, Jaeil Ahn, Michael B. Atkins, Neil J. Shah	2023	6
15	DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity Cell & Bioscience ·Shiwen Peng, Barbara Ma, Shu‐Hsia Chen, Chien‐Fu Hung, T-C Wu	2011	5
16	The clinical development of obinutuzumab for the treatment of follicular lymphoma Cancer Management and Research ·Barbara Ma, Chaitra S. Ujjani	2017	4
17	Real-world assessment of prophylactic anakinra on neurotoxicity after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis Blood ·Neela Easwar, Mia Andreoli, Herman van Besien, Caitlin Gribbin, Michelle Pasciolla, Anna Alperovich, Mateo Mejia-Saldarriaga, Barbara Ma, Nora Chokr, Amer Assal, Joshua Fein, Sebastian Mayer, Alexandra Gomez-Arteaga, Daniel Choi, Tsiporah B. Shore, Chris Hackett, Juliet N. Barker, Samuel Yamshon	2025	0

About Barbara Ma

Barbara Ma is a scholar working on Immunology, Oncology, Epidemiology, Molecular Biology and Genetics, having authored 17 papers that have together received 648 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Cervical Cancer and HPV Research (7 papers), Hepatitis B Virus Studies (6 papers), CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (3 papers), RNA Interference and Gene Delivery (2 papers), Virus-based gene therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Immunology (354 citations), Epidemiology (307 citations), Oncology (163 citations), Microbiology (31 citations) and Genetics (114 citations). Barbara Ma has collaborated with scholars based in United States, Taiwan and United Kingdom. Frequent co-authors include Chien‐Fu Hung, T.‐C. Wu, Archana Monie, T-C Wu, Ken Y. Lin, Anjui Wu, Yijie Xu, Niroshana Anandasabapathy, Tae Heung Kang and Chih-Long Chang. Their work appears in journals such as Molecular Therapy, Vaccine, Cell & Bioscience, Cancer and Journal of Investigative Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact